Blog

Home/Blog

Spotlight on Alan Wong

Alan Wong is CTVS’ longest-standing employee and has been with us since 1966. We like to say he’s 77-years young, not old! Alan works as a surgical technician assisting our board-certified cardiothoracic and vascular surgeons with complex procedures. He not only understands the delicate and serious nature of heart issues from the medical side, but he also knows firsthand what it is like to be a heart patient. Dr. Stephen Dewan, a CTVS cardiothoracic surgeon, performed bypass surgery on him in 1999.  When not caring for our patients, Alan can also be found underwater as an active volunteer with the [...]

February 18th, 2020|News|

We Heart American Heart Month

February is our favorite month of the year here at Cardiothoracic and Vascular Surgeons (CTVS) in Austin.  We love to show appreciation for our family, friends and patients in honor of American Heart Month. American Heart Month is a nationally designated event each February to bring awareness to and share the power of prevention in combating heart disease.  What is heart disease? Heart disease, or cardiovascular disease, includes a range of conditions that affect blood vessels, arteries, and heart rhythm. Heart disease also includes congenital heart defects, or those that are present at birth. Some of these conditions can be [...]

February 6th, 2020|News|

What is Thoracic Outlet Syndrome?

With the start of the new year, everyone is hitting the gym to make good on resolutions to get fit.  HIIT-specific workout centers especially are packed right now. HIIT—or high-intensity interval training—combines quick bursts of activity with short rest periods to maximize calorie burn.  It’s an effective workout for many, but it’s not without risk for injury. Common injuries as a result of HIIT workouts include muscle or tendon strains, joint dislocations, and fractures. Another serious condition that we are seeing increasingly at CTVS Texas  in HIIT devotees is Thoracic Outlet Syndrome. What is Thoracic Outlet Syndrome? Thoracic Outlet Syndrome [...]

January 27th, 2020|News|

CTVS Physicians Earn Texas Monthly Super Doctors Recognition

We are continuing to enjoy important accolades from the medical community with several of our Cardiothoracic and Vascular Surgeons (CTVS) physicians earning recognition in Texas Monthly as a 2019 Super Doctor® or Super Doctor® Rising Star. Texas Monthly Super Doctors are selected each year by MSP Communications from across the state via a rigorous multi-step process in a variety of medical specialties.  Among the things taken into consideration for this honor are peer recommendations, patient input, and exceptional professional achievement. Our CTVS Super Doctors are: Vascular Jeffrey Apple Phillip Church Mazin Foteh Brannon Hyde Jeffrey Jobe David Nation* John Politz Scott Seidel [...]

January 16th, 2020|News|

Austin Monthly Names Its Top Doctors

At Cardiothoracic and Vascular Surgeons (CTVS), our physicians strive to perform at the top of their game -- providing heartfelt patient care and unparalleled medical expertise-- each and every day. So it is especially rewarding when we are recognized for actually being “Top Doctors” in our local community.  Austin Monthly recently named their Top Doctors for 2020, and we are honored to have several of our team members make the list again, including: Thoracic and Cardiac Surgery Stephen J. Dewan Mark C. Felger Eric M. Hoenicke Faraz Kerendi William F. Kessler Vascular  Surgery Jeffrey M. Apple Mazin I. Foteh Jeffrey [...]

January 10th, 2020|News|

Convergent Procedure CONVERGE IDE Clinical Trial

Volume 14 - Issue 5 - May 2014 Posted on: 4/23/14 0 Comments 979 reads Start Page: 27 End page: 29 Author(s): Interview by Jodie Elrod In this feature interview we learn more about the multicenter CONVERGE Study, nContact’s randomized IDE Study for the treatment of persistent atrial fibrillation (AF) through a multidisciplinary closed-chest approach. The CONVERGE Study will randomize patients 2:1 between nContact’s epicardial-endocardial Convergent Procedure using the EPi-Sense™-AF guided Coagulation System with VisiTrax® and standalone endocardial ablation using fluid-irrigated catheters. Here EP Lab Digest® speaks with physicians from the first two sites to enroll patients in theCONVERGE Study: [...]

June 2nd, 2014|News|

CTVS Surgeons Perform Innovative Heart Surgery

Newer surgery technique eliminates chest scar and reduces recovery time Austin, TX – September 28, 2010 Cardiothoracic surgeons at Cardiothoracic and Vascular Surgeons, P.A. (CTVS) now perform minimally-invasive heart surgery to treat heart valve defects. About 95,000 Americans undergo heart valve procedures each year for valve defects, complications caused by congenital defects, aging, deterioration, or an untreated infection. If left untreated, heart valve problems can lead to heart failure or life-threatening cardiomyopathy, a serious disease where the heart muscle becomes weakened and does not function properly. Traditionally, surgeons perform heart valve procedures with "open chest" techniques where they divide the breastbone [...]

May 13th, 2014|News|

Heart Pump Heaps Hope on Patients

AUSTIN (KXAN) - It's been three years now since surgeons began using a new heart pump inside patients' bodies and they couldn't be happier with the results. The first HeartMate II™ ventricular assistive devices, or VAD s, began to be used at Seton Hospital in 2008, to keep patients alive until they could get a heart transplant. Two years later the same device was approved for use in patients who either didn't want a transplant or who were not eligible for one. In both cases, surgeons are grinning. "The technology has advanced so much that now we're able to do [...]

May 13th, 2014|Latest News|

Cardiothoracic & Vascular Surgeons
The First In Texas To Enroll In Global Clinical Trial For New Carotid Artery Treatment

FOR IMMEDIATE RELEASE New Procedure Designed to Help Safely Open Blocked Carotid Arteries Less Invasively September 17, 2013 – Austin, Texas – Cardiothoracic and Vascular Surgeons is the first in Texas to enroll patients in the ROADSTER Study, a global, multicenter clinical trial evaluating the safety and efficacy of the Silk Road™ System for the treatment of carotid artery disease.  Dr. Mazin Foteh and Dr. Jeffrey Apple, board-certified vascular surgeons, performed the procedure on two patients. Every year, more than 300,000 people in the United States are diagnosed with blockages, or plaques, in their carotid artery.  If left untreated, these [...]

May 13th, 2014|News|